Delivery Order SPE2DV17D0200-SPE2DV24FTYTG

Award Date 8/18/24
Potential Completion Date 9/9/24
Potential Value $5.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Waukegan, IL 60085, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,363.76, was issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is a Delivery Order (SPE2DV25FTKGZ) under an existing Indefinite Delivery Contract (IDC) with DLA, designated SPE2DM20D6509, which has a ceiling value of up to $4,999,999. The contract is for the delivery of a HEMOSTAT ABS 4X8IN 12S medical supply item, which supports the needs of military treatment facilities and other...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract (SPE2DV17D0200|SPE2DV25FTLEB) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., for the supply of 4,566,320,645 units of "HEMOSTAT ABS 4X8IN 12S" medical supplies. The $2,727.52 contract has a completion date of November 26, 2024 and is not set aside for small businesses. This award is part of Cardinal Health 200, LLC's existing Indefinite Delivery Contract (SPE2DM20D6509)...
This federal contract award with ID SPE2DV17D0200|SPE2DV24FTTMP was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The $2,727.52 Firm Fixed Price delivery order is for the procurement of 4564438067 HEMOSTAT ABS 4X8IN 12S medical supplies. The award has an ultimate completion date of May 20, 2024 and was issued on April 29, 2024. Cardinal Health 200, LLC is a major supplier of...
This federal contract award, valued at $2,930.88, was issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of 4568454609 - HEMOSTAT ABS 4X8IN 12S, a medical supply item. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of June 27, 2025. The contract is not set-aside. Cardinal Health 200, LLC is a for-profit limited liability company that specializes in medical and...
This federal contract award (SPE2DV17D0700|SPE2DV24FYHSL) was issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., a major supplier of medical and pharmaceutical products to the U.S. government. The $2,746.69 firm fixed-price delivery order is for the supply of HEMOSTAT ABS 4X8IN 12S, a surgical dressing product. The contract has an ultimate completion date of September 27, 2024. Cardinal Health 200, LLC is not a small business...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of HEMOSTAT ABS 4X8IN 12S medical supplies, with a ceiling value of $2,727.52. The contract is a firm fixed-price delivery order, with a period of performance through January 23, 2025. Cardinal Health 200, LLC is a major supplier of medical and pharmaceutical products to the U.S. federal government, including the military...
This federal contract award, with a ceiling value of $1,363.76, was issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) with DLA, contract number SPE2DM20D6509, which has a ceiling value of up to $4,999,999. The contract is for the procurement of a HEMOSTAT ABS 4X8IN 12S medical supply item, which supports military treatment facilities and other...
This federal contract award, identified as SPE2DV17D0200|SPE2DV25FTQES, was issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of HEMOSTAT ABS 4X8IN 12S medical supplies, with a ceiling value of $1,363.76. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 20, 2025. Cardinal Health 200, LLC is a major healthcare services and products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The $4,159.08 firm fixed-price delivery order is for the supply of "AGENT HEMOSTAT BLD 5S" medical products. The contract has a ceiling value of $4,159.08 and is set to expire on December 20, 2024. Cardinal Health 200, LLC is a major supplier of medical and pharmaceutical products to the U.S. federal government, supporting military treatment...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Cardinal Health 200, LLC, a subsidiary of the major healthcare services company Cardinal Health, Inc. The $1,363.76 firm-fixed-price delivery order is for the supply of medical hemostats, which are absorbent pads used to control bleeding. The contract has a completion date of February 21, 2025 and was not set aside for small businesses. Cardinal Health 200, LLC holds several Indefinite Delivery Contracts (IDCs)...
  • SPE2DV17D0200
    Indefinite Delivery Contract
  • SPE2DV17D0200-SPE2DV24FTYTG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) on August 18, 2024 to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The $5,455.04 Firm Fixed Price contract is for the delivery of 4565489822 HEMOSTAT ABS 4X8IN 12S medical supplies. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between DLA and Cardinal Health 200, LLC, with a potential value of up to $4,999,999 and an effective period through August 2027. This IDC allows DLA to rapidly procure a wide range of medical and pharmaceutical products to support military treatment facilities and DoD customers. The award does not utilize a small business set-aside.

Generated 11/17/24, 9:01 AM